Spots Global Cancer Trial Database for concurrent chemoradiotherapy
Every month we try and update this database with for concurrent chemoradiotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Hematopoietic Stem Cell-containing Autologous Blood Transfusion for Bone Marrow Protection in Patients With Cervical Cancer | NCT05401175 | Cervical Cancer | Autologous bloo... | 18 Years - 60 Years | Chongqing University Cancer Hospital | |
| Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin | NCT02562599 | Nasopharyngeal ... | raltitrexed-cis... Intensity-modul... | 18 Years - 70 Years | Hubei Cancer Hospital | |
| Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | NCT04437329 | Nasopharyngeal ... | Docetaxel, neda... Docetaxel, cisp... Nedaplatin Cisplatin Intensity modul... | 18 Years - 65 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma | NCT02801487 | Nasopharyngeal ... | Carbon ion radi... Cisplatin | 18 Years - 70 Years | Shanghai Proton and Heavy Ion Center | |
| Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma | NCT04376866 | Recurrent Nasop... | Toripalimab | 18 Years - 65 Years | Cancer Hospital of Guangxi Medical University | |
| Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | NCT04437329 | Nasopharyngeal ... | Docetaxel, neda... Docetaxel, cisp... Nedaplatin Cisplatin Intensity modul... | 18 Years - 65 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2 | NCT02132143 | Lung Adenocarci... | intensity-modul... intensity-modul... | 18 Years - 75 Years | People's Hospital of Guangxi | |
| Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma | NCT04004871 | Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Can... | Nab-paclitaxel,... concurrent chem... | 18 Years - 60 Years | Guangxi Medical University | |
| Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma | NCT02858206 | Esophageal Neop... | IMRT simultaneo... Nimotuzumab Paclitaxel Nedaplatin Esophagectomy | 18 Years - 69 Years | ChineseAMS | |
| Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer | NCT06419673 | Cervical Cancer | Serplulimab Cisplatin Carboplatin Brachytherapy a... | 18 Years - 70 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy | NCT05622474 | Nasopharyngeal ... | Induction chemo... Concurrent chem... IMRT | 18 Years - 70 Years | Sun Yat-sen University | |
| Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | NCT01245959 | Nasopharyngeal ... | Docetaxel, cisp... Concurrent chem... | 18 Years - 59 Years | Sun Yat-sen University | |
| The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma | NCT01187238 | Nasopharyngeal ... | cisplatin | 18 Years - 70 Years | ChineseAMS | |
| The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma | NCT01187238 | Nasopharyngeal ... | cisplatin | 18 Years - 70 Years | ChineseAMS | |
| Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC) | NCT00431613 | Non Small Cell ... | Docetaxel Gemcitabine Carboplatin Chemoradiothera... Docetaxel | 19 Years - 75 Years | Hellenic Oncology Research Group | |
| Study Of Candonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer | NCT05687851 | Locally Advance... | Candonilimab（AK... EBRT BT | 18 Years - | Chongqing University Cancer Hospital | |
| Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer | NCT02075385 | Head Neck Cance... Swallowing Diso... | pre, during and... | 18 Years - | Barretos Cancer Hospital | |
| Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma | NCT02969473 | Esophageal Neop... Chemoradiation | Docetaxel Fluorouracil | 18 Years - 70 Years | Sun Yat-sen University | |
| A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | NCT01479504 | Nasopharyngeal ... | nedaplatin and ... cisplatin and d... nedaplatin and ... cisplatin and d... | 18 Years - 70 Years | Guangxi Medical University | |
| Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma | NCT06048926 | Esophageal Squa... | Carrelizumab Paclitaxel inje... Cisplatin Concurrent chem... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age | NCT06354218 | Esophageal Carc... | Serplulimab | 75 Years - | The First Affiliated Hospital with Nanjing Medical University | |
| Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer | NCT02022852 | Rectal Cancer | Capecitabine XELOX | 18 Years - | Harbin Medical University | |
| Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma | NCT04380480 | Esophageal Squa... | Concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
| Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma | NCT03086681 | Cervical Carcin... | Endostar DDP | 18 Years - 65 Years | First Affiliated Hospital of Guangxi Medical University | |
| CCRT for Esophageal Cancer. | NCT02607982 | Esophageal Canc... Concurrent Chem... Oxaliplatin Paclitaxel | Paclitaxel Oxaliplatin Radiotherapy | 18 Years - 80 Years | Hangzhou Cancer Hospital | |
| Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma | NCT06342167 | Locally Advance... Sintilimab Radiotherapy Concurrent Chem... Immunonutrition | Radiotherapy Programmed Cell... Immunonutrition... | 18 Years - 80 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy | NCT04418648 | Small Cell Lung... | Toripalimab | 18 Years - 75 Years | Sun Yat-sen University | |
| Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE) | NCT05621707 | Esophageal Squa... Concurrent Chem... Immunotherapy Chemotherapy | chemotherapy co... | 18 Years - 75 Years | Shanghai Chest Hospital | |
| Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor | NCT03663764 | Thymoma and Thy... | Thymosin a1 hypofractionate... concurrent chem... | 18 Years - 70 Years | Sun Yat-sen University | |
| Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma | NCT06048926 | Esophageal Squa... | Carrelizumab Paclitaxel inje... Cisplatin Concurrent chem... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2 | NCT02132143 | Lung Adenocarci... | intensity-modul... intensity-modul... | 18 Years - 75 Years | People's Hospital of Guangxi | |
| Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer | NCT01180166 | Gastric Cancer Concurrent Chem... | nimotuzumab | 18 Years - 75 Years | ChineseAMS | |
| Involved Field Irradiation (IFI) Versus Elective Nodal Irradiation (ENI) for Esophageal Cancer | NCT01551589 | Esophageal Squa... | Involved Field ... docetaxel and c... Elective Nodal ... | 18 Years - 80 Years | The Second People's Hospital of Sichuan | |
| CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer | NCT04481100 | Esophageal Neop... Esophageal Dise... Esophageal Squa... | itraconazole | 18 Years - 75 Years | Hangzhou Cancer Hospital | |
| Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer | NCT00714077 | Rectal Neoplasm... | 18 Years - 75 Years | ChineseAMS | ||
| CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer | NCT00154804 | Esophageal Canc... | Paclitaxel, Cis... | 18 Years - | National Taiwan University Hospital | |
| Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Concurrent Chemotherapy and Intensity-modulated Radiotherapy | NCT02949596 | Anal Cancer Quality of Life | Quality of life... | - | Instituto do Cancer do Estado de São Paulo | |
| Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients | NCT03672136 | Carcinoma, Non-... | Anlotinib Concurrent Chem... | 18 Years - 75 Years | Shandong Cancer Hospital and Institute | |
| Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer | NCT03579004 | Esophageal Neop... Squamous Cell C... Concurrent Chem... | Paclitaxel Cisplatin Fluorouracil chemoradiothera... Ivor Lewis esop... | 18 Years - 75 Years | Russian Academy of Medical Sciences | |
| Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age | NCT06048913 | Esophageal Carc... | Nimotuzumab Tigio Concurrent radi... | 70 Years - | The First Affiliated Hospital with Nanjing Medical University | |
| Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer | NCT01938105 | Locally Advance... | Nimotuzumab+che... | 18 Years - 75 Years | People's Hospital of Guangxi | |
| Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients | NCT03672136 | Carcinoma, Non-... | Anlotinib Concurrent Chem... | 18 Years - 75 Years | Shandong Cancer Hospital and Institute | |
| A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | NCT04636762 | Extensive-stage... | Radiation Thera... | 18 Years - 75 Years | Second Xiangya Hospital of Central South University | |
| A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | NCT00201396 | Nasopharyngeal ... | CCRT Mitomycin C,Epi... | - 70 Years | National Health Research Institutes, Taiwan | |
| Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors | NCT02776163 | Salivary Gland ... Head and Neck C... | Cisplatin Docetaxel Intensity-modul... | 18 Years - 70 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients | NCT02604472 | Malignant Neopl... | CCRT IC+CCRT | - | Sun Yat-sen University | |
| Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma | NCT06342167 | Locally Advance... Sintilimab Radiotherapy Concurrent Chem... Immunonutrition | Radiotherapy Programmed Cell... Immunonutrition... | 18 Years - 80 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients | NCT04061278 | Nasopharyngeal ... Neoadjuvant Che... | 4 cycles of Neo... 3 cycles of Neo... | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer | NCT02075385 | Head Neck Cance... Swallowing Diso... | pre, during and... | 18 Years - | Barretos Cancer Hospital | |
| Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT05527782 | Locally Advance... | modified TPF Quality of life... | 18 Years - | Hospital Universitario Doctor Peset | |
| Total Neoadjuvant Therapy in Rectal Cancer Treatment | NCT04747951 | Rectal Cancer | Concurrent Chem... TME consolidation c... adjuvant chemot... | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | |
| Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients | NCT02454647 | Gastric Cancer Adenocarcinoma Effects of Chem... Surgery Gastrointestina... | Induction chemo... Radiotherapy wi... Salvage surgery | 18 Years - 80 Years | Clinica Universidad de Navarra, Universidad de Navarra | |
| Nedaplatin in Treatment for Nasopharyngeal Carcinoma | NCT04834206 | Nasopharyngeal ... | Docetaxel, neda... IMRT Nedaplatin | 18 Years - 65 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors | NCT03177382 | Total Neoadjuva... Chemoradiothera... Local Advanced ... High Risk Facto... | Total neoadjuva... concurrent chem... TME Adjuvant chemot... | 18 Years - 70 Years | West China Hospital | |
| Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC | NCT06288373 | Cervical Cancer Locally Advance... Concurrent Chem... Neoadjuvant Che... | Camrelizumab Cisplatin Nab paclitaxel Radical surgery external beam r... Cisplatin | 18 Years - 70 Years | Tongji Hospital | |
| Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy | NCT02289807 | Nasopharyngeal ... | Cisplatin IMRT | 18 Years - 70 Years | Sun Yat-sen University | |
| A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | NCT00201396 | Nasopharyngeal ... | CCRT Mitomycin C,Epi... | - 70 Years | National Health Research Institutes, Taiwan | |
| A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer | NCT02459457 | Stage III Esoph... | Paclitaxel and ... Paclitaxel and ... Paclitaxel and ... Radiotherapy | 18 Years - 75 Years | Fudan University | |
| CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer | NCT00154804 | Esophageal Canc... | Paclitaxel, Cis... | 18 Years - | National Taiwan University Hospital | |
| Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer | NCT05799469 | Locally Advance... | Envafolimab Cisplatin External Beam R... Brachytherapy (... | 18 Years - 75 Years | Chongqing University Cancer Hospital | |
| Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC | NCT03503136 | Nasopharyngeal ... | docetaxel, neda... nedaplatin docetaxel, cisp... cisplatin docetaxel, cisp... docetaxel, neda... | 18 Years - 60 Years | Sun Yat-sen University | |
| Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC | NCT02688036 | Carcinoma, Smal... Lung Neoplasms | hypofractionate... conventionally ... | 18 Years - 70 Years | ChineseAMS | |
| Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma | NCT04380480 | Esophageal Squa... | Concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
| Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma | NCT03908372 | Stage II, III Nasopharyngeal ... Induction Chemo... Concurrent Chem... Reduce Treatmen... | Docetaxel Cisplatin IMRT | 18 Years - 70 Years | ChineseAMS | |
| Hematopoietic Stem Cell-containing Autologous Blood Transfusion for Bone Marrow Protection in Patients With Cervical Cancer | NCT05401175 | Cervical Cancer | Autologous bloo... | 18 Years - 60 Years | Chongqing University Cancer Hospital | |
| Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma | NCT04380480 | Esophageal Squa... | Concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
| Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer. | NCT04368273 | Cervical Cancer | PD-1 antibody | 18 Years - 75 Years | Peking University Third Hospital | |
| Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer. | NCT04368273 | Cervical Cancer | PD-1 antibody | 18 Years - 75 Years | Peking University Third Hospital | |
| Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | NCT04414566 | Nasopharyngeal ... | gemcitabine and... IMRT IMRT and concur... | 18 Years - 65 Years | West China Hospital | |
| Sarcopenia and Multimodal Rehabilitation on the Prognosis of Rectal Cancer Patients Receiving CCRT | NCT05664607 | Rectal Cancer | for excise, nut... | 20 Years - 85 Years | Chang Gung Memorial Hospital | |
| Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer | NCT06391190 | Locally Advance... Concurrent Chem... Immunotherapy | Albumin-Bound P... | 18 Years - 75 Years | RenJi Hospital | |
| The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients | NCT06349148 | Cervical Cancer... | enteral immunon... standard oral e... | 18 Years - | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC | NCT01854203 | Nasopharyngeal ... | Inductive chemo... Inductive chemo... | 18 Years - 65 Years | Sun Yat-sen University | |
| Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | NCT00677118 | Nasopharyngeal ... | Cisplatin,fluor... Cisplatin | 18 Years - 69 Years | Sun Yat-sen University | |
| Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients | NCT05374252 | Anal Canal Canc... Anal Squamous C... Anal Canal Canc... Anal Cancer | PD-1 inhibitor concurrent chem... | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma | NCT03086681 | Cervical Carcin... | Endostar DDP | 18 Years - 65 Years | First Affiliated Hospital of Guangxi Medical University | |
| PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy | NCT05980715 | HNSCC Radiotherapy PD-1 | PD-1inhibitor concurrent chem... | 18 Years - 65 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | NCT01479504 | Nasopharyngeal ... | nedaplatin and ... cisplatin and d... nedaplatin and ... cisplatin and d... | 18 Years - 70 Years | Guangxi Medical University | |
| Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma | NCT02858206 | Esophageal Neop... | IMRT simultaneo... Nimotuzumab Paclitaxel Nedaplatin Esophagectomy | 18 Years - 69 Years | ChineseAMS | |
| Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer | NCT04542356 | Cervical Cancer | PEG-rhG-CSF rhG-CSF | 18 Years - 70 Years | Chongqing University Cancer Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
